Post Marketing Surveillance of MENOPUR
NCT01202123 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2501
Last updated 2014-02-21
Summary
The purpose of this study is to evaluate the safety and efficacy of highly purified (HP) menotrophine to Korean women.
Conditions
Sponsors & Collaborators
-
Ferring Pharmaceuticals
lead INDUSTRY
Principal Investigators
-
Clinical Development Support · Ferring Pharmaceuticals
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-12-31
- Primary Completion
- 2013-11-30
- Completion
- 2014-02-28
Countries
- South Korea
Study Locations
More Related Trials
-
MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population
NCT02554279 ·Status: COMPLETED ·Phase: PHASE4
-
Age-related Variability of the Efficacy and Tolerability of Alternative Pituitary Suppression Regimens in ART
NCT01107470 ·Status: UNKNOWN
-
A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy Women
NCT04902131 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)
NCT04163458 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study in in Vitro Fertilisation (IVF) Patients
NCT01312766 ·Status: COMPLETED ·Phase: PHASE3
-
Post-Marketing Surveillance (PMS) Protocol of REKOVELLE Pre-Filled Pen (Follitropin Delta)
NCT04654039 ·Status: COMPLETED
-
A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa
NCT00257556 ·Status: COMPLETED ·Phase: PHASE4
-
MENOPUR in Gonadotrophin-releasing Hormone (GnRH) Antagonist Cycles With Single Embryo Transfer
NCT00884221 ·Status: COMPLETED ·Phase: PHASE3
-
Gonadotrophin Dosage Using a Threshold Nomogram for Ovulation Induction in WHO Group II Anovulatory Infertility
NCT01250821 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Assessment of the Clinical Utility of Ovarian Stimulation With Menotropin Versus Menotropin Plus GnRH Antagonist
NCT01331733 ·Status: COMPLETED
-
Retrospective Cohort Observational Study to Evaluate the Effectiveness and Safety of Fresh or Frozen Embryo Transfer
NCT05130125 ·Status: COMPLETED
-
Observational Study to Develop Dosing Chart
NCT04227171 ·Status: COMPLETED
-
A Study to Measure Relationship Between Antimüllerian Hormone and Initial Dose of Menopur®
NCT02935335 ·Status: COMPLETED
-
Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women
NCT01340521 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Elucidating Kisspeptin Physiology by Blocking Kisspeptin Signaling
NCT01438073 ·Status: COMPLETED ·Phase: PHASE1
-
Follow-up Protocol on the Outcome of Frozen-thawed Embryo Transfer Cycles From Clinical Trial P05690 (P05711)
NCT00702546 ·Status: COMPLETED
-
An Explorative Prospective Observational Study to Describe Morphokinetic De-selection Parameters in Human Embryos
NCT02018159 ·Status: COMPLETED
-
Menopur And Rekovelle Combination Study Version 2.0
NCT06997900 ·Status: RECRUITING ·Phase: PHASE2
-
Protocol to Minimize Injections and Blood Draws for Women Undergoing in Vitro Fertilization
NCT02865681 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Efficacy and Safety of Highly Purified Urofollitropin in Chinese Females Undergoing an Assisted Reproductive Technology (ART) Program
NCT01922193 ·Status: COMPLETED ·Phase: PHASE3
-
Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles
NCT05112692 ·Status: UNKNOWN ·Phase: NA
-
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Dosage Strengths of Pulsatile GnRH
NCT00296465 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)
NCT00805935 ·Status: COMPLETED ·Phase: PHASE4
-
MENOPUR® Versus FOLLISTIM®
NCT00802360 ·Status: COMPLETED ·Phase: PHASE4
-
An Observational Study of Cetrotide® Gonadotropin-releasing Hormone Antagonist (GnRH Antagonist) With GONAL-f® in Assisted Reproductive Technologies (ART)
NCT01109654 ·Status: COMPLETED